Agomelatine Offers Renewed Hope for Depressed Patients across the GCC
 

24-09-11 04:00 PM

Agomelatine is registered and available in Europe since 2009 and has been registered by the ministry of health in Kuwait, Bahrain, Oman, Qatar and the UAE, and will soon be available for the treatment of adult patients suffering from MDD across the Gulf countries.

Source...